Management of human epidermal growth factor receptor 2-negative metastatic breast cancer: Role of poly adenosine diphosphate (ADP-ribose) polymerase inhibitors.

Vaid, Ashok Kumar; Deshmukh, Chetan; Rohatgi, Nitesh; Ghosh, Joydeep

Vaid, Ashok Kumar; Deshmukh, Chetan; Rohatgi, Nitesh; Ghosh, Joydeep.

Afiliación

Vaid AK; Department of Medical Oncology, Medanta - The Medicity, Gurugram, Haryana, India.
Deshmukh C; Department of Medical Oncology, Dinanath Mangeshkar Hospital, Pune, Maharashtra, India.
Rohatgi N; Department of Medical Oncology, Max Superspeciality Hospital, Saket, New Delhi, India.
Ghosh J; Department of Medical Oncology, TMC, Kolkata, West Bengal, India.

Indian J Cancer ; 59(Supplement): S130-S141, 2022 Mar.

Article en En | MEDLINE | ID: mdl-35343197

Asunto(s)

Neoplasias de la Mama; Ribosa; Adenosina Difosfato/uso terapéutico; Adenosina Difosfato Ribosa/uso terapéutico; Neoplasias de la Mama/patología; Femenino; Humanos; Receptor ErbB-2; Ribosa/uso terapéutico

Palabras clave

HER2-negative breast cancer; HR-positive HER2-negative breast cancer; PARP inhibitors; TNBC; olaparib; talazoparib

Texto completo

Imprimir

XML

PubMed Links

Buscar en Google

Texto completo: 1 Banco de datos: MEDLINE Asunto principal: Ribosa / Neoplasias de la Mama Límite: Female / Humans Idioma: En Revista: Indian J Cancer Año: 2022 Tipo del documento: Article País de afiliación: India

Texto completo

Imprimir

XML

PubMed Links

Buscar en Google